Vaccines

Human Challenge Studies in Infectious Disease: Despite Need for Rigorous Oversight, Studies Are Vital

Human Challenge Studies in Infectious Disease: Despite Need for Rigorous Oversight, Studies Are Vital

By

Barriers to challenge studies include ethical guidelines indicating that the generation of scientific knowledge should never supersede the rights and interests of research subjects.

HPV Vaccine Under Priority Review for Expanded Age Range

HPV Vaccine Under Priority Review for Expanded Age Range

By

Specifically, the types the vaccine protects against are HPV 16, 18, 31, 33, 45, 52, 58 (which cause ~90% of cervical cancer cases worldwide), and types 6 and 11 which case genital warts.

CDC: Get Vaccinated for Measles Before Traveling

CDC: Get Vaccinated for Measles Before Traveling

By

The CDC recommends 2 doses of the MMR vaccine, which provides 97% protection against measles, prior to international travel.

Varicella Zoster Vaccine Effective for Hematopoietic Stem Cell Transplant Recipients

Varicella Zoster Vaccine Effective for Hematopoietic Stem Cell Transplant Recipients

By

In a phase 3 clinical trial, early vaccination effectively prevented herpes zoster in auto-HSCT recipients.

Increase in Requirement for Influenza Vaccinations at Non-VA Hospitals

Increase in Requirement for Influenza Vaccinations at Non-VA Hospitals

At non VA hospitals, but not in VA hospitals, there was an increase in mandatory influenza vaccination requirements for health care personnel from 2013 to 2017.

No New Adverse Events Reported for DTaP Vaccination

No New Adverse Events Reported for DTaP Vaccination

No new or unexpected safety issues have been identified in association with DTaP vaccines in the US

Platform Manufacturing May Speed Pandemic Vaccine Development

Platform Manufacturing May Speed Pandemic Vaccine Development

By

With the advent of platform manufacturing technology, vaccines can be developed quickly to stop the spread of outbreaks.

CDC: Administration Errors Reported With New Shingles Vaccine

CDC: Administration Errors Reported With New Shingles Vaccine

By

Between October 20, 2017 and February 20, 2018, the Vaccine Adverse Event Reporting System (VAERS) received 155 reports involving RZV, with 13 (8%) involving an administrative error.

New AAP Policy on Patient Dismissal for Vaccine Refusal May "Erode Solidarity" Among Pediatricians

New AAP Policy on Patient Dismissal for Vaccine Refusal May "Erode Solidarity" Among Pediatricians

By

Others have argued that dismissal is ethically problematic because it can deprive children of comprehensive pediatric care and undermine public health.

Study Supports Development of a Vaccine for Recurrent Vulvovaginal Candidiasis

Study Supports Development of a Vaccine for Recurrent Vulvovaginal Candidiasis

By

Results support further development of NDV-3A vaccine and provide guidance for meaningful clinical endpoints for immunotherapeutic management of recurrent vulvovaginal candidiasis.

WHO Issues Position Paper for Typhoid Fever Vaccine

WHO Issues Position Paper for Typhoid Fever Vaccine

By

The World Health Organization recommends vaccination in cases of confirmed outbreaks of typhoid fever, although data on the use of vaccines in controlling outbreaks are very limited and research to assess the value of vaccination in these cases is strongly recommended.

MenACWY-TT Vaccine Can Be Effectively Coadministered With Routine Pediatric Immunizations

MenACWY-TT Vaccine Can Be Effectively Coadministered With Routine Pediatric Immunizations

By

Study showed that DTPa-HBV-IPV/Hib and PHiD-CV coadministered with MenACWY-TT in infants and toddlers were immunogenic with an acceptable reactogenicity profile.

HPV Vaccination May Offer Protection Against Cervical Precancer

HPV Vaccination May Offer Protection Against Cervical Precancer

By

The authors concluded, "There is high-certainty evidence that HPV vaccines protect against cervical precancer in adolescent girls and young women aged 15 to 26," while also indicated that future studies should have long-term follow-up.

Effect of Pneumococcal Vaccination With PCV10 on All-Cause Acute Otitis Media

Effect of Pneumococcal Vaccination With PCV10 on All-Cause Acute Otitis Media

By

In this whole-population study, researchers demonstrated a 22% vaccine effect of the 10-valent pneumococcal conjugate vaccine on all-cause acute otitis media.

Vaccine for Chikungunya Prevention Gets Fast Track Designation

Vaccine for Chikungunya Prevention Gets Fast Track Designation

By

The Phase 2b study is in the process of enrolling 400 people to evaluate multiple dosing regimens. PaxVax expects the results in early 2019.

The 'Attitude Roots' Underlying Antivaccination Beliefs

The 'Attitude Roots' Underlying Antivaccination Beliefs

By

Although efforts to debunk antivaccination beliefs often rely on fact-based strategies, emerging evidence suggests it may be more effective to target the psychological roots of these beliefs.

Are Vaccines Associated With Multiple Sclerosis Relapse?

Are Vaccines Associated With Multiple Sclerosis Relapse?

By

Researchers found there are no associations between vaccinations and multiple sclerosis relapse flares.

FDA to Review Fluzone Quadrivalent 0.5mL Dose for Younger Patients

FDA to Review Fluzone Quadrivalent 0.5mL Dose for Younger Patients

By

The sBLA included clinical data from a Phase 4 study that enrolled nearly 2000 children and assessed the safety and immunogenicity of the 0.5mL dose.

Single-Dose Ebola Vaccine Durable for 1 to 2 Years

Single-Dose Ebola Vaccine Durable for 1 to 2 Years

By

Study provides new data on the durability of the humoral immune response up to 2 years after single-dose injection with rVSV-ZEBOV vaccine in a population of primarily European ancestry, and additional data on durability at 1 year after vaccination in 2 African populations.

Season and Year of Birth an Emergent Risk Factor for Rotavirus

Season and Year of Birth an Emergent Risk Factor for Rotavirus

By

Researchers found being born in an odd calendar year, especially in the winter or fall seasons, emerged as a risk factor for rotavirus in the postvaccine era in the United States.

MenB Vaccine Gets Breakthrough Therapy Designation for Children Ages 1-9 Years

MenB Vaccine Gets Breakthrough Therapy Designation for Children Ages 1-9 Years

By

The FDA has granted Breakthrough Therapy designation to Trumenba for immunization caused by Neisseria meningitidis group B in children.

CDC: Recommendations on the Use of Heplisav-B Published

CDC: Recommendations on the Use of Heplisav-B Published

By

The CDC has published ACIP recommendations regarding the use of Heplisav-B.

ACOG: Updated Recommendations for Influenza Vaccination During Pregnancy

ACOG: Updated Recommendations for Influenza Vaccination During Pregnancy

By

This updated Committee Opinion includes more recent data on the safety and efficacy of influenza vaccination during pregnancy, as well as recommendations for treatment and postexposure chemoprophylaxis.

Adult Caregivers Likely to Receive Influenza Vaccination From Pediatric Clinics

Adult Caregivers Likely to Receive Influenza Vaccination From Pediatric Clinics

By

Adult caretaker influenza vaccination cocooning programs can prove beneficial and financially successful in private practice models where external funding is limited or not available.

Inactivated Quadrivalent Flu Vaccine Highly Efficacious in Children Aged 6-35 Months

Inactivated Quadrivalent Flu Vaccine Highly Efficacious in Children Aged 6-35 Months

By

Study adds to the body of existing evidence to support universal vaccination of all children from 6 months of age, irrespective of risk status, to prevent influenza in this age group and to reduce the spread of influenza in the general population.

Efficacy of Adjuvanted vs Conventional Quadrivalent Flu Vaccine Compared

Efficacy of Adjuvanted vs Conventional Quadrivalent Flu Vaccine Compared

By

MF59 adjuvanted, quadrivalent influenza vaccine (aQIV) was found to be more efficacious in preventing influenza than a non-adjuvanted conventional influenza vaccine in children aged 6 through 23 months.

An Effective Zika Vaccine May Eliminate Prenatal Infections

An Effective Zika Vaccine May Eliminate Prenatal Infections

By

A vaccine against Zika virus, once available and effectively deployed, may substantially reduce prenatal infections.

Herpes Zoster in Healthy Children Linked to Varicella-Zoster Vaccination

Herpes Zoster in Healthy Children Linked to Varicella-Zoster Vaccination

By

The morphology of the lesions included erythematous papules, pseudovesicles, and plaques, with associated pain in 2 and pruritus in 3 patients; systemic symptoms ranged from none to low‐grade fevers, upper respiratory symptoms, and joint pain.

Increased Risk for Acute Respiratory Illness Following Influenza Vaccine in Children

Increased Risk for Acute Respiratory Illness Following Influenza Vaccine in Children

By

Among children there was an increased risk for acute respiratory illness caused by noninfluenza respiratory pathogens following influenza vaccination compared to unvaccinated children during the same period.

A Zika vaccine could virtually eliminate prenatal infections

A Zika virus vaccine shown to be of moderate to high efficacy in eliminating prenatal infections provides 90% coverage.

Sign Up for Free e-newsletters